Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5704)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2021 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lei GL, Niu Y, Cheng SJ, Li YY, Bai ZF, Yu LX, Hong ZX, Liu H, Liu HH, Yan J, Gao Y, Zhang SG, Chen Z, Li RS, Yang PH. Upregulation of long noncoding RNA W42 promotes tumor development by binding with DBN1 in hepatocellular carcinoma. World J Gastroenterol 2021; 27(20): 2586-2602 [PMID: 34092977 DOI: 10.3748/wjg.v27.i20.2586] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i20/2586.htm |
| Number | Citing Articles |
| 1 |
Bing Jiang, Kankan Yang, Chao Tang, Rui Chen, Chao Wang. LncRNA LINC01270 aggravates the progression of gastric cancer through modulation of miR-326/EFNA3 axis. Bioengineered 2022; 13(4): 8995 doi: 10.1080/21655979.2022.2054204
|
| 2 |
Guozheng Pan, Jian Zhang, Faping You, Tao Cui, Peng Luo, Shuling Wang, Xiaomei Li, Qingzhong Yuan. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1. Bioengineered 2022; 13(1): 1346 doi: 10.1080/21655979.2021.2017565
|
| 3 |
Yanan Yang, Yongqing Li, Haonan Yuan, Xuanbo Liu, Yue Ren, Caixia Gao, Ting Jiao, Yuan Cai, Shengguo Zhao. Integrative Analysis of the lncRNA-Associated ceRNA Regulatory Network Response to Hypoxia in Alveolar Type II Epithelial Cells of Tibetan Pigs. Frontiers in Veterinary Science 2022; 9 doi: 10.3389/fvets.2022.834566
|
| 4 |
Ahmad Khan, Xiaobo Zhang. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials. Bioengineering 2022; 9(8): 406 doi: 10.3390/bioengineering9080406
|
| 5 |
Qian Liu, Chunfu Zhu, Yanfen Dong. LncRNA TCTN2 Promotes the Malignant Development of Hepatocellular
Carcinoma via Regulating mIR-1285-3p/ARF6 Axis. Recent Patents on Anti-Cancer Drug Discovery 2023; 18(4): 517 doi: 10.2174/1574892818666221019163656
|
| 6 |
Rongfang Pan, Junyu Zhao, Jinming Yao, Yanyan Gao, Lin Liao. Selenomethionine Suppress the Progression of Poorly Differentiated Thyroid
Cancer via LncRNA NONMMUT014201/miR-6963-5p/Srprb Pathway. Combinatorial Chemistry & High Throughput Screening 2024; 27(16): 2419 doi: 10.2174/0113862073286006231228070738
|
| 7 |
Qi Wang, Qiong Fang, Yanping Huang, Jin Zhou, Meimei Liu. Identification of a novel prognostic signature for HCC and analysis of costimulatory molecule-related lncRNA AC099850.3. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13792-z
|
| 8 |
I. Saranya, V. Sowfika Dharshini, R.L. Akshaya, P. Sakthi Subhashini, N. Selvamurugan. Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review. International Journal of Biological Macromolecules 2024; 266: 131075 doi: 10.1016/j.ijbiomac.2024.131075
|
| 9 |
Adane Adugna, Yalew Muche, Abateneh Melkamu, Mohammed Jemal, Habtamu Belew, Gashaw Azanaw Amare. Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy. Heliyon 2024; 10(14): e34288 doi: 10.1016/j.heliyon.2024.e34288
|
| 10 |
Chou Yang, Lingyan Zhang, Xin Hao, Mengdie Tang, Bin Zhou, Jinlin Hou. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification. Current Oncology 2022; 30(1): 430 doi: 10.3390/curroncol30010035
|
| 11 |
Swarnalatha Kodidela, Abhayananda Behera, Aramati Bindu Madhava Reddy. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 341 doi: 10.1016/B978-0-323-98806-3.00020-9
|
| 12 |
Fatemeh Movahedi Motlagh, Sepideh Kadkhoda, Maryam Motamedrad, Parisa Javidzade, Sheyda Khalilian, Mohammad Hossein Modarressi, Soudeh Ghafouri-Fard. Roles of non-coding RNAs in cell death pathways involved in the treatment of resistance and recurrence of cancer. Pathology - Research and Practice 2023; 247: 154542 doi: 10.1016/j.prp.2023.154542
|
| 13 |
Juan Lu, Zhaoying Xiao, Mengqiu Xu, Lanjuan Li. New Insights into LINC00346 and its Role in Disease. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.819785
|